These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16322237)

  • 21. MDA-9/syntenin: a positive gatekeeper of melanoma metastasis.
    Das SK; Bhutia SK; Kegelman TP; Peachy L; Oyesanya RA; Dasgupta S; Sokhi UK; Azab B; Dash R; Quinn BA; Kim K; Barral PM; Su ZZ; Boukerche H; Sarkar D; Fisher PB
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):1-15. PubMed ID: 22201728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1.
    Kim WY; Jang JY; Jeon YK; Chung DH; Kim YG; Kim CW
    Exp Mol Med; 2014 Apr; 46(4):e90. PubMed ID: 24722482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis.
    Sarkar D; Boukerche H; Su ZZ; Fisher PB
    Cancer Res; 2008 May; 68(9):3087-93. PubMed ID: 18451132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting tumor invasion: the roles of MDA-9/Syntenin.
    Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB
    Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β.
    Pradhan AK; Maji S; Bhoopathi P; Talukdar S; Mannangatti P; Guo C; Wang XY; Cartagena LC; Idowu M; Landry JW; Sarkar D; Emdad L; Cavenee WK; Das SK; Fisher PB
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34016751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.
    Das SK; Sarkar D; Emdad L; Fisher PB
    Adv Cancer Res; 2019; 144():137-191. PubMed ID: 31349898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.
    Sarkar D; Su ZZ; Lebedeva IV; Sauane M; Gopalkrishnan RV; Valerie K; Dent P; Fisher PB
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):10054-9. PubMed ID: 12114539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
    Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
    Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mda-9/Syntenin protein positively regulates the activation of Akt protein by facilitating integrin-linked kinase adaptor function during adhesion to type I collagen.
    Hwangbo C; Park J; Lee JH
    J Biol Chem; 2011 Sep; 286(38):33601-12. PubMed ID: 21828040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tandem PDZ domains of syntenin promote cell invasion.
    Meerschaert K; Bruyneel E; De Wever O; Vanloo B; Boucherie C; Bracke M; Vandekerckhove J; Gettemans J
    Exp Cell Res; 2007 May; 313(9):1790-804. PubMed ID: 17451681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
    Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells.
    Lebedeva IV; Su ZZ; Chang Y; Kitada S; Reed JC; Fisher PB
    Oncogene; 2002 Jan; 21(5):708-18. PubMed ID: 11850799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo.
    Labelle-Côté M; Dusseault J; Ismaïl S; Picard-Cloutier A; Siegel PM; Larose L
    BMC Cancer; 2011 Oct; 11():443. PubMed ID: 21992144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
    Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
    Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
    Givant-Horwitz V; Davidson B; Reich R
    Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling.
    Dasgupta S; Menezes ME; Das SK; Emdad L; Janjic A; Bhatia S; Mukhopadhyay ND; Shao C; Sarkar D; Fisher PB
    Clin Cancer Res; 2013 Sep; 19(17):4621-33. PubMed ID: 23873690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis.
    Maji S; Pradhan AK; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Windle JJ; Subler MA; Wang XY; Semmes OJ; Nyalwidhe JO; Mukhopadhyay N; Paul AK; Hatfield B; Levit MM; Madan E; Sarkar D; Emdad L; Cohen DJ; Gogna R; Cavenee WK; Das SK; Fisher PB
    Proc Natl Acad Sci U S A; 2023 Nov; 120(45):e2307094120. PubMed ID: 37922327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling.
    Choi Y; Yun JH; Yoo J; Lee I; Kim H; Son HN; Kim IS; Yoon HS; Zimmermann P; Couchman JR; Cho HS; Oh ES; Lee W
    Sci Rep; 2016 Nov; 6():36818. PubMed ID: 27830760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syntenin regulates TGF-β1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-β type I receptor internalization.
    Hwangbo C; Tae N; Lee S; Kim O; Park OK; Kim J; Kwon SH; Lee JH
    Oncogene; 2016 Jan; 35(3):389-401. PubMed ID: 25893292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.
    Das SK; Maji S; Wechman SL; Bhoopathi P; Pradhan AK; Talukdar S; Sarkar D; Landry J; Guo C; Wang XY; Cavenee WK; Emdad L; Fisher PB
    Pharmacol Res; 2020 May; 155():104695. PubMed ID: 32061839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.